Ascent Wealth Partners’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.02M Buy
6,833
+101
+2% +$30K 0.23% 90
2025
Q4
$1.84M Sell
6,732
-83
-1% -$22.6K 0.21% 93
2025
Q3
$1.84M Sell
6,815
-122
-2% -$33.2K 0.21% 95
2025
Q2
$1.91M Sell
6,937
-28
-0.4% -$7.61K 0.24% 86
2025
Q1
$1.85M Buy
6,965
+31
+0.4% +$7.65K 0.25% 85
2024
Q4
$1.61M Buy
6,934
+3,221
+87% +$741K 0.22% 84
2024
Q3
$819K Buy
+3,713
New +$768K 0.11% 109

Other funds holding CME

Ascent Wealth Partners's CME Position: Q1 2026 in Review

Ascent Wealth Partners increased its CME Group (CME) stake by 1.5% in Q1 2026, buying an estimated $30K and bringing the position to 6,833 shares worth $2.02M. The position accounts for 0.23% of the portfolio, ranked #90.

Ascent Wealth Partners first reported a position in CME in Q3 2024 and has held it in 7 quarters since. 1,790 funds tracked by Wall St. Rank hold CME as of Q1 2026.

  • Ascent Wealth Partners held 6,833 shares of CME Group worth $2.02M as of Q1 2026.
  • Ascent Wealth Partners bought 101 CME Group shares in Q1 2026, an estimated $30K.
  • CME Group made up 0.23% of Ascent Wealth Partners's portfolio in Q1 2026, its #90 holding.
  • Ascent Wealth Partners first reported a position in CME Group in Q3 2024 and has held it in 7 quarters since.
  • 1,790 funds tracked by Wall St. Rank held CME Group as of Q1 2026.

Based on Ascent Wealth Partners's 13F filing for Q1 2026, filed 6 May 2026.